Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 2/20 | 0.45 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.44 |
| ▸ | SORD | Q00796 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 9/20 | 0.40 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23837044 | 0.80 | MAP4K4 (0.50) | MAP4K4CXCR4 | |
| SCHEMBL22014121 | 0.76 | KIT (0.46) | — | |
| SCHEMBL22013645 | 0.73 | MAP4K4 (0.55) | MAP4K4CXCR4SORD | |
| SCHEMBL22013086 | 0.73 | NTRK1 (0.51) | — | |
| SCHEMBL29692877 | 0.73 | NTRK1 (0.51) | — | |
| SCHEMBL29692833 | 0.73 | NTRK1 (0.51) | — | |
| SCHEMBL22013243 | 0.72 | MAPK8 (0.47) | MAP4K4MKNK1MKNK2 | |
| SCHEMBL22013643 | 0.72 | MAP4K4 (0.61) | MAP4K4CXCR4 | |
| SCHEMBL23836983 | 0.72 | MAP4K4 (0.54) | MAP4K4GBA1 | |
| SCHEMBL22013226 | 0.72 | MAP4K4 (0.54) | MAP4K4CXCR4SORD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882247-A1 | SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR | Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) | 2021-09-22 | — | — | EP | disclosed |
| WO-2020098723-A1 | SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR | 上海轶诺药业有限公司 | 2020-05-22 | — | — | WO | disclosed |